PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy. Read more about PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. Read more about Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor.
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. Read more about A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Read more about The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Read more about Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Read more about Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
Establishment and serial passage of cell cultures derived from LuCaP xenografts. Read more about Establishment and serial passage of cell cultures derived from LuCaP xenografts.
Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. Read more about Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.
Inhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis. Read more about Inhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.
Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia. Read more about Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia.
